Patent details

Basic Information

Publication number:

EP1104407

PCT Application Number:

PCT/US/2000/015795

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP009396995

PCT Publication Number:

WO/2001/000586

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPOUNDS AS SELECTIVE AGONISTS AT ALPHA 2B OR 2B/2C ADRENERGIC RECEPTORS

French Title of Invention:

COMPOSES UTILISABLES COMME AGONISTES SELECTIFS DES RECEPTEURS ADRENERGIQUES ALPHA 2B OU 2B/2C

German Title of Invention:

VERBINDUNGEN ALS SELEKTIVE AGONISTEN DER ALPHA 2B ODER 2B/2C ADRENERGISCHE REZEPTOREN

SPC Number:

Dates

Filing date:

08/06/2000

Grant date:

01/12/2004

EP Publication Date:

01/12/2004

PCT Publication Date:

04/01/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/06/2001

EP B1 Publication Date:

01/12/2004

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/06/2005

Expiration date:

08/06/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/06/2000

 

 

Name:

Allergan Inc.

Address:

2525 Dupont Drive,, Irvine, CA 92612, United States (US)

Inventor

1

Name:

BURKE James, A.

Address:

United States (US)

2

Name:

CHOW Ken

Address:

United States (US)

3

Name:

GIL Daniel, W.

Address:

United States (US)

4

Name:

GARST Michael, E.

Address:

United States (US)

5

Name:

MUNK Stephen, A.

Address:

United States (US)

6

Name:

WHEELER Larry, A.

Address:

United States (US)

7

Name:

HARCOURT Dale, A.

Address:

United States (US)

Priority

Priority Number:

329752

Priority Date:

10/06/1999

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 233/54;

Filing date	Document type	Number of pages